Physician profile
Carlos E Reyes
NPI 1629247515
$1,424.67
in general payments reported to CMS, 2019-2025
25 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $234 · 2021: $67.32 · 2022: $457 · 2023: $115 · 2024: $102 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $483.72 | 2019-2022 | |
| Astellas Pharma US INC | $105.06 | 2024-2025 | Veozah |
| Dysis Medical, INC. | $96.33 | 2020 | |
| Abbvie INC. | $81.39 | 2019-2025 | |
| Baxter Healthcare | $76.32 | 2023-2025 | Floseal, Tisseel |
| Amgen INC. | $62.94 | 2019-2020 | |
| Conmed Corporation | $44.48 | 2020 | |
| Novo Nordisk INC | $42.63 | 2025 | Wegovy |
| Pfizer INC. | $42.46 | 2020-2023 | |
| Coopersurgical, INC. | $42.09 | 2019-2023 | Summit Doppler |
| Otsuka America Pharmaceutical, INC. | $38.80 | 2019-2021 | |
| Organon LLC | $34.33 | 2024-2025 | Jada System |
| Mayne Pharma Commercial LLC | $34.06 | 2025 | |
| Therapeuticsmd, INC. | $27.18 | 2020 | |
| Merck Sharp & Dohme LLC | $26.77 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $24.36 | 2024 | Slynd |
| Sage Therapeutics, LLC | $21.05 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $21.05 | 2025 | Qelbree |
| Hologic Sales and Service, LLC | $20.23 | 2024 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Myriad Women'S Health, INC. | $20.11 | 2023 | Myrisk |
| Scynexis, INC. | $18.65 | 2022 | |
| American Regent | $16.55 | 2025 | Injectafer |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Gynesonics, INC. | $14.45 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Olympus America INC. | $13.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.